|
GB9423910D0
(en)
*
|
1994-11-26 |
1995-01-11 |
Pfizer Ltd |
Therapeutic agents
|
|
IL120266A
(en)
|
1996-02-28 |
2005-05-17 |
Pfizer |
Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
|
|
GB9612514D0
(en)
*
|
1996-06-14 |
1996-08-14 |
Pfizer Ltd |
Novel process
|
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
|
SK285991B6
(sk)
|
1997-04-25 |
2008-01-07 |
Pfizer Inc. |
Pyrazolopyrimidinóny, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutické a veterinárne kompozície na ich báze
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
EP1371647B1
(en)
*
|
1998-04-20 |
2005-07-13 |
Pfizer Inc. |
Pyridine-3-carboxylic acid derivatives and their use as intermediates
|
|
DE19827640A1
(de)
|
1998-06-20 |
1999-12-23 |
Bayer Ag |
7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
|
|
GB9822238D0
(en)
*
|
1998-10-12 |
1998-12-09 |
Pfizer Ltd |
Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
|
|
GB9823102D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
GB9823103D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
GB9823101D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
KR100353014B1
(ko)
*
|
1998-11-11 |
2002-09-18 |
동아제약 주식회사 |
발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
|
|
RU2220145C2
(ru)
*
|
1998-11-11 |
2003-12-27 |
Донг А Фарм. Ко., Лтд. |
Производные пиразолопиримидинона для лечения импотенции и способ их получения
|
|
US6225315B1
(en)
|
1998-11-30 |
2001-05-01 |
Pfizer Inc |
Method of treating nitrate-induced tolerance
|
|
NO20002097L
(no)
*
|
1999-04-30 |
2001-10-26 |
Lilly Icos Llc |
Fremstillingsgjenstander
|
|
CA2365782A1
(en)
*
|
1999-04-30 |
2000-11-09 |
William E. Pullman |
Treatment of female arousal disorder
|
|
JP3145364B2
(ja)
|
1999-06-04 |
2001-03-12 |
ザ・ヨルダニアン・フアーマシユーテイカル・エム・エフ・ジー・アンド・メデイカル・イクイツプメント・カンパニー・リミテツド |
新規化合物及び該化合物を含有する医薬組成物
|
|
ATE228134T1
(de)
*
|
1999-06-04 |
2002-12-15 |
Jordanian Pharmaceutical Mfg A |
Kondensierte pyrimidinderivate und diese enthaltende pharmazeutische zubereitungen
|
|
ES2166270B1
(es)
*
|
1999-07-27 |
2003-04-01 |
Almirall Prodesfarma Sa |
Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona.
|
|
DE19942474A1
(de)
*
|
1999-09-06 |
2001-03-15 |
Merck Patent Gmbh |
Pyrazolo[4,3-d]pyrimidine
|
|
EP1222190A1
(en)
|
1999-10-11 |
2002-07-17 |
Pfizer Limited |
5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors
|
|
GB9923968D0
(en)
*
|
1999-10-11 |
1999-12-15 |
Pfizer Ltd |
Therapeutic agents
|
|
US6350751B1
(en)
|
1999-10-11 |
2002-02-26 |
Pfizer Inc. |
Therapeutic agents
|
|
TWI265925B
(en)
*
|
1999-10-11 |
2006-11-11 |
Pfizer |
Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
|
|
YU59100A
(sh)
*
|
1999-10-11 |
2003-10-31 |
Pfizer Inc. |
Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
|
|
TW200400821A
(en)
*
|
1999-11-02 |
2004-01-16 |
Pfizer |
Pharmaceutical composition (II) useful for treating or preventing pulmonary hypertension in a patient
|
|
WO2001047928A2
(de)
*
|
1999-12-24 |
2001-07-05 |
Bayer Aktiengesellschaft |
Imidazo 1,3,5 triazinone und ihre verwendung
|
|
CA2395410A1
(en)
*
|
1999-12-24 |
2001-07-05 |
Bayer Aktiengesellschaft |
Triazolotriazinones and the use thereof
|
|
KR100358083B1
(ko)
*
|
2000-02-17 |
2002-10-25 |
에스케이케미칼주식회사 |
피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도
|
|
WO2001087888A1
(en)
*
|
2000-05-17 |
2001-11-22 |
Sk Chemicals Co., Ltd. |
Pyrazolopyrimidinone derivatives, process for their preparation and their use
|
|
KR100377782B1
(ko)
*
|
2000-06-23 |
2003-03-29 |
동아제약 주식회사 |
발기부전 치료에 효과를 갖는 피라졸로피리미디논화합물의 제조방법
|
|
US6407259B1
(en)
|
2000-07-28 |
2002-06-18 |
Pfizer Inc. |
Process for the preparation of pyrazoles
|
|
EP1176142A1
(en)
*
|
2000-07-28 |
2002-01-30 |
Pfizer Inc. |
Process for the preparation of pyrazoles
|
|
AU2001276607A1
(en)
*
|
2000-08-11 |
2002-02-25 |
Pfizer Inc. |
Treatment of the insulin resistance syndrome with selective CGMP PDE5 inhibitors
|
|
PE20020394A1
(es)
|
2000-08-18 |
2002-06-21 |
Agouron Pharma |
Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
|
|
WO2002016364A1
(en)
*
|
2000-08-23 |
2002-02-28 |
Lg Life Sciences Ltd. |
Polyethoxylated pyrazolo pyrimidinone derivatives, process for preparation thereof and pharmaceutical compositions comprising the same for the treatment of impotence
|
|
US6821978B2
(en)
|
2000-09-19 |
2004-11-23 |
Schering Corporation |
Xanthine phosphodiesterase V inhibitors
|
|
GB0025782D0
(en)
*
|
2000-10-20 |
2000-12-06 |
Pfizer Ltd |
Use of inhibitors
|
|
US6548508B2
(en)
|
2000-10-20 |
2003-04-15 |
Pfizer, Inc. |
Use of PDE V inhibitors for improved fecundity in mammals
|
|
SE0004780D0
(sv)
|
2000-12-22 |
2000-12-22 |
Jordanian Pharmaceutical Mfg & |
Novel compunds
|
|
WO2003042216A1
(en)
|
2001-11-09 |
2003-05-22 |
Schering Corporation |
Polycyclic guanine derivative phosphodiesterase v inhibitors
|
|
GB0129274D0
(en)
*
|
2001-12-06 |
2002-01-23 |
Pfizer Ltd |
Novel kit
|
|
ATE478872T1
(de)
|
2002-03-28 |
2010-09-15 |
Ustav Ex Botan Av Cr V V I I O |
Pyrazoloä4,3-düpyrimidine, verfahren zu ihrer herstellung und therapeutische anwendung
|
|
GB0219961D0
(en)
|
2002-08-28 |
2002-10-02 |
Pfizer Ltd |
Oxytocin inhibitors
|
|
US7323462B2
(en)
|
2002-12-10 |
2008-01-29 |
Pfizer Inc. |
Morpholine dopamine agonists
|
|
DE60332387D1
(de)
|
2002-12-13 |
2010-06-10 |
Warner Lambert Co |
Alpha-2-delta-ligand zur behandlung vonsymptomen der unteren harnwege
|
|
EA008596B1
(ru)
|
2003-04-29 |
2007-06-29 |
Пфайзер Инк. |
5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
|
|
WO2005012256A1
(en)
|
2003-07-22 |
2005-02-10 |
Astex Therapeutics Limited |
3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
|
|
US7291640B2
(en)
|
2003-09-22 |
2007-11-06 |
Pfizer Inc. |
Substituted triazole derivatives as oxytocin antagonists
|
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
|
EP1779852A3
(en)
*
|
2004-01-05 |
2007-05-09 |
Teva Pharmaceutical Industries Ltd. |
Processes for the production of sildenafil base and citrate salt
|
|
US7618976B2
(en)
|
2004-01-05 |
2009-11-17 |
Teva Pharmaceutical Industries Ltd |
Methods for the production of sildenafil base and citrate salt
|
|
JP2007518788A
(ja)
|
2004-01-22 |
2007-07-12 |
ファイザー・インク |
バソプレッシンのアンタゴニスト活性を阻害するトリアゾール誘導体
|
|
US7649002B2
(en)
|
2004-02-04 |
2010-01-19 |
Pfizer Inc |
(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
|
|
DK1742950T3
(da)
|
2004-04-07 |
2009-03-16 |
Pfizer Ltd |
Pyrazolo-[4,3-D]-pyrimidiner
|
|
US7897607B2
(en)
*
|
2004-04-07 |
2011-03-01 |
Takeda Pharmaceutical Company Limited |
Cyclic compounds
|
|
CA2577442A1
(en)
|
2004-08-17 |
2006-03-02 |
The Johns Hopkins University |
Pde5 inhibitor compositions and methods for treating cardiac indications
|
|
TWI367098B
(en)
*
|
2004-12-23 |
2012-07-01 |
Kowa Co |
Treating agent for glaucoma
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
ES2313626T3
(es)
|
2005-03-21 |
2009-03-01 |
Pfizer Limited |
Derivados de triazol sustituidos como antagonistas de oxitocina.
|
|
BRPI0610498A2
(pt)
|
2005-04-19 |
2010-06-22 |
Nycomed Gmbh |
uso de roflumilast,composição farmacêutica, produto de combinação e kit para o tratamento de hipertensão pulmonar
|
|
US8506934B2
(en)
|
2005-04-29 |
2013-08-13 |
Robert I. Henkin |
Methods for detection of biological substances
|
|
CA2608018C
(en)
|
2005-05-12 |
2010-07-13 |
Pfizer Inc. |
Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
|
|
ZA200804550B
(en)
|
2005-11-09 |
2009-08-26 |
Combinatorx Inc |
Methods, compositions, and kits for the treatment of medical conditions
|
|
JP2007169278A
(ja)
*
|
2005-12-20 |
2007-07-05 |
Pfizer Prod Inc |
Ｌｕｔｓ処置用の医薬組合せ
|
|
GB0601951D0
(en)
|
2006-01-31 |
2006-03-15 |
Novartis Ag |
Organic compounds
|
|
WO2008095136A2
(en)
|
2007-01-31 |
2008-08-07 |
Henkin Robert I |
Methods for detection of biological substances
|
|
US8580801B2
(en)
|
2008-07-23 |
2013-11-12 |
Robert I. Henkin |
Phosphodiesterase inhibitor treatment
|
|
CN101747282A
(zh)
|
2008-12-10 |
2010-06-23 |
上海特化医药科技有限公司 |
一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途
|
|
JP2012513464A
(ja)
|
2008-12-23 |
2012-06-14 |
ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク |
ホスホジエステラーゼ阻害剤及びその使用
|
|
GB0903493D0
(en)
|
2009-02-27 |
2009-04-08 |
Vantia Ltd |
New compounds
|
|
TWI462739B
(zh)
|
2010-11-02 |
2014-12-01 |
Univ Kaohsiung Medical |
Ｓｉｌｄｅｎａｆｉｌ－同族物四級銨哌嗪鹽類之製備及醫療用途
|
|
US8815271B2
(en)
|
2010-11-03 |
2014-08-26 |
Dow Agrosciences, Llc. |
Pesticidal compositions and processes related thereto
|
|
CN102134242B
(zh)
*
|
2011-01-21 |
2013-08-28 |
浙江大德药业集团有限公司 |
一种用于治疗阳痿的快速长效的化合物
|
|
JP2014526461A
(ja)
*
|
2011-09-09 |
2014-10-06 |
エスケー ケミカルズ カンパニー，リミテッド |
Ｐｄｅ５抑制剤を含む皮膚しわ改善用組成物
|
|
US8937083B2
(en)
|
2011-10-26 |
2015-01-20 |
DowAgroSciences, LLC |
Pesticidal compositions and processes related thereto
|
|
WO2013067309A1
(en)
|
2011-11-04 |
2013-05-10 |
Xion Pharmaceutical Corporation |
Methods and compositions for oral administration of melanocortin receptor agonist compounds
|
|
EP2804603A1
(en)
|
2012-01-10 |
2014-11-26 |
President and Fellows of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
|
WO2013109738A1
(en)
|
2012-01-17 |
2013-07-25 |
The Trustees Of Columbia University In The City Of New York |
Novel phosphodiesterase inhibitors and uses thereof
|
|
US9708288B2
(en)
|
2012-04-27 |
2017-07-18 |
Dow Agrosciences Llc |
Pesticidal compositions and processes related thereto
|
|
US9282739B2
(en)
|
2012-04-27 |
2016-03-15 |
Dow Agrosciences Llc |
Pesticidal compositions and processes related thereto
|
|
RU2627654C2
(ru)
|
2012-04-27 |
2017-08-09 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Пестицидные композиции и относящиеся к ним способы
|
|
WO2014055801A1
(en)
|
2012-10-05 |
2014-04-10 |
Henkin Robert I |
Phosphodiesterase inhibitors for treating taste and smell disorders
|
|
ES2882258T3
(es)
|
2012-12-21 |
2021-12-01 |
Mayo Found Medical Education & Res |
Métodos y materiales para tratar estenosis de la válvula aórtica calcificada
|
|
CN103265479B
(zh)
*
|
2013-06-14 |
2017-12-08 |
南开大学 |
一种6‑氯甲基烟酸叔丁酯的合成方法
|
|
WO2015009930A2
(en)
|
2013-07-17 |
2015-01-22 |
The Trustees Of Columbia University In The City Of New York |
Novel phosphodiesterase inhibitors and uses thereof
|
|
EP3057430A4
(en)
|
2013-10-17 |
2017-09-13 |
Dow AgroSciences LLC |
Processes for the preparation of pesticidal compounds
|
|
CN105636440A
(zh)
|
2013-10-17 |
2016-06-01 |
美国陶氏益农公司 |
制备杀虫化合物的方法
|
|
CN105636446B
(zh)
|
2013-10-17 |
2018-07-13 |
美国陶氏益农公司 |
制备杀虫化合物的方法
|
|
KR20160075565A
(ko)
|
2013-10-17 |
2016-06-29 |
다우 아그로사이언시즈 엘엘씨 |
살충성 화합물의 제조 방법
|
|
BR112016008070B8
(pt)
|
2013-10-17 |
2022-08-23 |
Dow Agrosciences Llc |
Compostos pesticidas, e seus processos de preparação
|
|
JP2016535010A
(ja)
|
2013-10-17 |
2016-11-10 |
ダウ アグロサイエンシィズ エルエルシー |
有害生物防除性化合物の製造方法
|
|
EP3057426A4
(en)
|
2013-10-17 |
2017-03-29 |
Dow AgroSciences LLC |
Processes for the preparation of pesticidal compounds
|
|
AR098101A1
(es)
|
2013-10-22 |
2016-05-04 |
Dow Agrosciences Llc |
Composiciones plaguicidas y métodos relacionados
|
|
AR098094A1
(es)
|
2013-10-22 |
2016-05-04 |
Dow Agrosciences Llc |
Composiciones plaguicidas sinérgicas y métodos relacionados
|
|
EP3060044A4
(en)
|
2013-10-22 |
2017-04-05 |
Dow AgroSciences LLC |
Synergistic pesticidal compositions and related methods
|
|
CN105828608A
(zh)
|
2013-10-22 |
2016-08-03 |
美国陶氏益农公司 |
杀虫组合物和与其相关的方法
|
|
MX2016005319A
(es)
|
2013-10-22 |
2016-08-12 |
Dow Agrosciences Llc |
Composiciones pesticidas y metodos relacionados.
|
|
EP3060054A4
(en)
|
2013-10-22 |
2017-04-05 |
Dow AgroSciences LLC |
Synergistic pesticidal compositions and related methods
|
|
US9497966B2
(en)
|
2013-10-22 |
2016-11-22 |
Dow Agrosciences Llc |
Pesticidal compositions and related methods
|
|
CN105792652A
(zh)
|
2013-10-22 |
2016-07-20 |
美国陶氏益农公司 |
协同杀虫组合物和相关方法
|
|
US9137998B2
(en)
|
2013-10-22 |
2015-09-22 |
Dow Agrosciences Llc |
Pesticidal compositions and related methods
|
|
WO2015061140A1
(en)
|
2013-10-22 |
2015-04-30 |
Dow Agrosciences Llc |
Synergistic pesticidal compositions and related methods
|
|
JP2016538265A
(ja)
|
2013-10-22 |
2016-12-08 |
ダウ アグロサイエンシィズ エルエルシー |
相乗的有害生物防除組成物および関連する方法
|
|
CA2927226A1
(en)
|
2013-10-22 |
2015-04-30 |
Dow Agrosciences Llc |
Synergistic pesticidal compositions and related methods
|
|
RU2658995C2
(ru)
|
2013-10-22 |
2018-06-26 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Пестицидные композиции и связанные с ними способы
|
|
CA2927206A1
(en)
|
2013-10-22 |
2015-04-30 |
Dow Agrosciences Llc |
Synergistic pesticidal compositions and related methods
|
|
US9155304B2
(en)
|
2013-10-22 |
2015-10-13 |
Dow Agrosciences Llc |
Synergistic pesticidal compositions and related methods
|
|
AR098091A1
(es)
|
2013-10-22 |
2016-05-04 |
Dow Agrosciences Llc |
Composiciones pesticidas sinérgicas y métodos relacionados
|
|
CN105792650A
(zh)
|
2013-10-22 |
2016-07-20 |
美国陶氏益农公司 |
协同杀虫组合物和相关方法
|
|
US10598672B2
(en)
|
2014-02-18 |
2020-03-24 |
Cyrano Therapeutics, Inc. |
Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
|
|
EP3174856A4
(en)
|
2014-07-31 |
2018-01-10 |
Dow AgroSciences LLC |
Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
|
|
EP3186229A4
(en)
|
2014-07-31 |
2018-01-10 |
Dow AgroSciences LLC |
Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
|
|
US9249122B1
(en)
|
2014-07-31 |
2016-02-02 |
Dow Agrosciences Llc |
Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
|
|
WO2016028328A1
(en)
|
2014-08-19 |
2016-02-25 |
Dow Agrosciences Llc |
Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
|
|
JP2017528469A
(ja)
|
2014-09-12 |
2017-09-28 |
ダウ アグロサイエンシィズ エルエルシー |
３−（３−クロロ−１ｈ−ピラゾール−１−イル）ピリジンの調製方法
|
|
IL292225B2
(en)
*
|
2014-09-17 |
2024-12-01 |
Intra Cellular Therapies Inc |
Derivatives of 5,7,7-trimethyl-[2H]-imidazo-[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one and pharmaceutical compositions comprising them.
|
|
WO2016145614A1
(en)
|
2015-03-17 |
2016-09-22 |
Merck Sharp & Dohme Corp. |
Triazolyl pyrimidinone compounds as pde2 inhibitors
|
|
WO2016183741A1
(en)
|
2015-05-15 |
2016-11-24 |
Merck Sharp & Dohme Corp. |
Pyrimidinone amide compounds as pde2 inhibitors
|
|
US20180072718A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
|
IL292977A
(en)
|
2016-09-09 |
2022-07-01 |
Incyte Corp |
Pyrazolopyridine derivatives as modulators of hpk1 and their use in cancer therapy
|
|
AR109595A1
(es)
|
2016-09-09 |
2018-12-26 |
Incyte Corp |
Compuestos de pirazolopirimidina y usos de estos como inhibidores de hpk1
|
|
US10100033B2
(en)
|
2016-12-29 |
2018-10-16 |
Dow Agrosciences Llc |
Processes for the preparation of pesticidal compounds
|
|
WO2018125817A1
(en)
|
2016-12-29 |
2018-07-05 |
Dow Agrosciences Llc |
Processes for the preparation of pesticidal compounds
|
|
WO2018152220A1
(en)
|
2017-02-15 |
2018-08-23 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
|
US10722495B2
(en)
|
2017-09-08 |
2020-07-28 |
Incyte Corporation |
Cyanoindazole compounds and uses thereof
|
|
US10752635B2
(en)
|
2018-02-20 |
2020-08-25 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
US10745388B2
(en)
|
2018-02-20 |
2020-08-18 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
JP7526673B2
(ja)
|
2018-02-20 |
2024-08-01 |
インサイト・コーポレイション |
がんを治療するためのｈｐｋ１阻害剤としてのｎ－（フェニル）－２－（フェニル）ピリミジン－４－カルボキサミド誘導体及び関連化合物
|
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
|
ES2973117T3
(es)
|
2018-09-25 |
2024-06-18 |
Incyte Corp |
Compuestos de pirazolo[4,3-d]pirimidina como moduladores de ALK2 y/o FGFR
|
|
EP3887376A1
(en)
*
|
2018-11-28 |
2021-10-06 |
Topadur Pharma AG |
Novel dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof
|
|
MX2021012409A
(es)
|
2019-04-10 |
2021-11-12 |
Mayo Found Medical Education & Res |
Metodos y materiales para el tratamiento dependiente del genero de la disfuncion cardiovascular.
|
|
KR20220059480A
(ko)
|
2019-08-06 |
2022-05-10 |
인사이트 코포레이션 |
고체 형태의 hpk1 억제제
|
|
WO2021194893A1
(en)
|
2020-03-24 |
2021-09-30 |
Cyrano Therapeutics, Inc. |
Treatment of chemosensory dysfunction from a coronavirus infection
|
|
CN113493459B
(zh)
*
|
2020-04-07 |
2022-12-13 |
广州白云山医药集团股份有限公司白云山制药总厂 |
Pde5抑制剂化合物及其制备方法和应用
|
|
CN113754612B
(zh)
*
|
2021-10-26 |
2023-09-26 |
山东安舜制药有限公司 |
一种西地那非中间体的制备方法
|
|
CN115785101B
(zh)
*
|
2022-11-23 |
2023-10-13 |
西安市食品药品检验所 |
一种含有苯基哌嗪结构的那非类化合物及其制备方法
|
|
CN116332856A
(zh)
*
|
2023-01-04 |
2023-06-27 |
荟达医药科技(上海)有限公司 |
一种4-哒嗪甲醇的合成方法
|